Bill DeLaney, Sysco president and chief executive officer, will lead the combined company, which will continue to be named Sysco and headquartered in Houston, Texas. At closing, Sysco will have estimated annual sales of approximately $65 billion.
Sysco will pay approximately $3.5 billion for the equity of US Foods, comprising $3 billion of Sysco common stock and $500 million of cash. As part of the transaction, Sysco will also assume or refinance US Foods' net debt, which is currently approximately $4.7 billion, bringing the total enterprise value to $8.2 billion. Sysco has secured fully committed bridge financing and expects to issue permanent financing prior to closing.
After completion of the transaction, the equity holders of US Foods will own approximately 87 million shares, or roughly 13% of Sysco. A representative of each of US Foods' majority shareholders, affiliates of Clayton, Dubilier & Rice LLC and Kohlberg Kravis Roberts & Co. L.P., will join Sysco's Board of Directors upon closing.
Bill DeLaney, Sysco president and chief executive officer, said, "As we continue on our transformational journey at Sysco, this transaction will position us to significantly accelerate our progress in achieving the vision we have for our company: to be our customers' most valued and trusted business partner. Sysco and US Foods have highly complementary core strengths including a broad product portfolio and passionate food people deeply committed to customer service, quality-assured products and safety. In particular we look forward to welcoming US Foods' talented employees and continuing to invest in the development of all of our people. Together we will strive to enhance shareholder value by providing our customers with highly differentiated products and services."
John Lederer, president and chief executive officer of US Foods, said, "Combining and maximizing the significant strengths of two outstanding companies is certain to be of tremendous advantage in supporting our customers as they tackle the challenges of today's demanding environment."
Compelling Strategic Rationale
This transaction will bring together Sysco and US Foods' complementary strengths including talented and dedicated associates, a broad product portfolio, supply chain excellence and a commitment to continuous improvement. Going forward, Sysco will continue to create value for customers through insights-driven product innovation and expanded services that go beyond food. Increased geographic coverage and scale will enhance our flexibility and responsiveness as we provide unique, on-trend food products that save customers time and improve performance.
At closing, the combined companies are expected to have annualized sales of approximately $65 billion and generate operating cash flows of approximately $2 billion. Sysco will purchase the outstanding equity of US Foods and assume or refinance its net debt in a transaction with an enterprise value of $8.2 billion. This represents a 9.9x multiple of US Foods' trailing 12-month (as of September 28, 2013) adjusted EBITDA of $826 million. Additionally, the transaction is expected to generate significant strategic benefits and cost synergies, achieving annual synergies of at least $600 million after three to four years, primarily stemming from supply chain efficiencies, merchandising activities, and overlapping general and administrative functions. The transaction is expected to be immediately accretive to earnings after adjusting for transaction-related costs and amortization of intangibles.
Sysco expects to maintain a strong investment grade rating. Additionally, Sysco is committed to continuing to invest in its dividend and returning value to shareholders. Sysco has paid a dividend every quarter since 1970 and has increased its dividend 45 times since becoming a public company.
Commitment to Investment
Sysco remains committed to investing in its businesses and its people to accelerate the transformation of the industry, including customer-friendly technology, robust category management, food safety and quality assurance and sustainable business practices.
Sysco will establish a team comprising members of both companies to prepare for and oversee a comprehensive integration for employees, customers and suppliers.
The transaction, which is expected to close in the third quarter of calendar year 2014, is subject to customary closing conditions and regulatory approvals, including antitrust approval.
Goldman, Sachs & Co. is serving as financial advisor to Sysco and Wachtell, Lipton, Rosen & Katz and Arnall, Golden & Gregory LLP are serving as its legal advisors. Simpson Thacher & Bartlett LLP and Debevoise & Plimpton LLP are serving as US Foods' legal advisors.
* Covidien plc (NYSE: COV) and Given Imaging Ltd (Nasdaq: GIVN) announced a definitive agreement under which Covidien will acquire all of the outstanding shares of Given Imaging for $30.00 per share in cash, for a total of approximately $860 million, net of cash and investments acquired. This transaction provides Covidien additional scale and scope to serve the multibillion dollar global gastrointestinal (GI) market and supports the Company’s strategy to comprehensively address key global specialties and procedures.
Given Imaging provides one of the broadest technology platforms for visualizing, diagnosing and monitoring the digestive system, including its flagship PillCam®, an innovative swallowed capsule endoscope.
Given Imaging is dedicated to developing innovative diagnostic and monitoring technologies for the digestive system. The company’s broad portfolio includes the PillCam, a minimally-invasive, non-sedation, swallowed optical endoscopy technology for the small bowel, esophagus and colon. In total, Given Imaging has seven product lines across 21 GI disease states. The company also offers industry-leading GI functional diagnostic solutions including ManoScan® high resolution manometry, Bravo® capsule-based pH monitoring, Digitrapper® pH-Z monitoring and SmartPill® motility monitoring systems.
The transaction is subject to customary closing conditions, including Given Imaging shareholder approval and the receipt of certain regulatory approvals, and is expected to be completed by March 31, 2014. The Boards of Directors of both companies have approved the transaction, and the Boards of Directors of DIC, Elron and Rdc, owners of 44 percent of Given's outstanding shares, have approved voting in favor of the transaction. DIC has also entered into a customary voting agreement with Covidien.
Covidien intends to finance the transaction through cash on hand and will report Given Imaging within the Medical Devices business segment. Upon closing of the transaction, Covidien expects Given Imaging will add between $40 and $50 million per quarter in incremental revenue to the Medical Devices segment.
On a reported U.S. GAAP basis, the transaction is expected to be dilutive to both operating margin and earnings per share (EPS) in fiscal 2014. On an adjusted basis, excluding one-time items and transaction costs, management expects the transaction to be neutral to both operating margin and EPS in fiscal 2014. The transaction is expected to be accretive to operating margin and EPS both on a U.S. GAAP and on an adjusted basis in fiscal 2015 and beyond. From a “cash earnings” standpoint, which excludes the impact of amortization, the transaction is expected to be accretive immediately after it closes.
Covidien management is not changing any of its guidance as a result of this transaction.
* Post Holdings (NYSE: POST) agreed to acquire Golden Boy Foods Ltd. ("Golden Boy") and Dymatize Enterprises, LLC ("Dymatize") in two unrelated transactions. These transactions further Post's efforts to expand into the private label and active nutrition categories.
Acquisition of Golden Boy Foods" Post has agreed to acquire privately owned Golden Boy from affiliates of Tricor Pacific Capital, Inc. and other shareholders. Golden Boy is a North American manufacturer of private label peanut and other nut butters, as well as dried fruit, baking and snacking nuts. Golden Boy is a key supplier to the U.S. and Canadian retail and foodservice channels and participates in the rapidly growing organic packaged foods category. The nut butter category is expected to remain strong with the U.S. nut butter retail category projected to grow at a compound annual growth rate of 13% between 2014 and 2017 (according to Mintel), and Post management believes Golden Boy is well positioned to participate in this category growth. Based near Vancouver, Golden Boy has a flexible production and distribution network which includes three plants in Canada and two in the U.S.
Post has agreed to pay CAD $320 million for Golden Boy on a cash-free, debt-free basis, subject to a working capital adjustment. For the nine months ended September 30, 2013, Golden Boy had net sales of CAD $164 million and Adjusted EBITDA of CAD $23 million. A reconciliation of Adjusted EBITDA to the nearest non-GAAP measure is provided later in this press release. In prior years, Golden Boy's net sales and Adjusted EBITDA in the fourth calendar quarter have been higher when compared to the average of the prior three quarters, and Post management expects this trend to continue for the fourth calendar quarter of this year. Post management expects that during calendar 2014, which extends beyond Post's fiscal 2014, Golden Boy will generate Adjusted EBITDA of CAD $34-36 million, before extraordinary, unusual or non-recurring items.
Post expects to combine the Golden Boy business with Dakota Growers Pasta Company, a pending acquisition expected to close in January 2014. The combined Golden Boy and Dakota Growers business will be managed by Richard Harris, current CEO of Golden Boy. The acquisitions establish Post's private label platform, creating a business with annual net sales in excess of $500 million for the twelve months ended September 30, 2013. The Golden Boy acquisition is anticipated to close on or around February 1, 2014, subject to customary closing conditions, including the receipt of approvals or the expiration of waiting periods under the Hart-Scott-Rodino Act and Canadian antitrust approval.
Golden Boy was represented by Lazard Middle Market LLC.
Acquisition of Dymatize Enterprises: Post has also entered into an agreement to acquire privately owned Dymatize from affiliates of TA Associates and other owners. Dymatize manufactures and markets premium protein powders, bars and nutritional supplements under the Dymatize and Supreme Protein brands. Dymatize's products participate in the rapidly growing sports nutrition supplement and nutrition bar categories. The global active nutrition category is expected to remain strong with the category projected to grow at a compound annual growth rate of 7% between 2014 and 2017 (according to Euromonitor). The Dymatize brand has been growing substantially in excess of the market and Post management expects the Dymatize brand to continue to outpace category growth. Dymatize's vertical integration and science-based model allows product customization for different end market consumers.
Post management believes the Dymatize acquisition complements its active nutrition focus by expanding its channel diversification. Post acquired Premier Nutrition Corporation in September 2013. Premier's distribution is primarily club and food/drug/mass, whereas Dymatize is primarily specialty and food/drug/mass. Dymatize will continue to be led by current President and CEO, Greg Venner.
Post has agreed to pay $380 million for Dymatize on a cash-free, debt-free basis and subject to a working capital adjustment, with additional consideration up to $17.5 million contingent upon Dymatize achieving certain profit targets in calendar year 2014. For the nine months ended September 30, 2013, Dymatize had net sales of $146 million and Adjusted EBITDA of $23 million. A reconciliation of Adjusted EBITDA to the nearest non-GAAP measure is provided later in this press release. Post management expects that during calendar 2014, which extends beyond Post's fiscal 2014, Dymatize will generate Adjusted EBITDA of $35-38 million, before extraordinary, unusual or non-recurring items.
The purchase of Dymatize is structured to allow Post to benefit from amortization of tax basis resulting in a net present value benefit expected to be approximately $40 -$45 million. The Dymatize transaction is expected to close on or around February 1, 2014, subject to customary closing conditions, including the expiration of waiting periods under the Hart-Scott-Rodino Act.
Dymatize was represented by BofA Merrill Lynch.
* Australia's Oil Search notes the announcements made by InterOil Corporation (NYSE: IOC) and Total SA (NYSE: TOT) on Friday with respect to the acquisition by Total SA of a strategic interest in Petroleum Retention Licence (PRL) 15 in Papua New Guinea (PNG).
As previously articulated to the market, Oil Search has been in discussions with a number of key stakeholders associated with the PRL 15 sale process.
To ensure that the market is fully informed, Oil Search confirms that these discussions are ongoing. However, the nature of Oil Search’s potential participation in any transaction is uncertain and there is no guarantee that any agreement will be reached.
Oil Search shareholders will be kept informed of any further material developments if and when they occur.
* BRE Properties, Inc. (NYSE: BRE) announced that its Board of Directors, working with its management team and the Company's advisors, has been in an ongoing process of exploring strategic alternatives to enhance shareholder value. The BRE Board has undertaken a comprehensive and thorough review of alternatives that include, among other things, a possible sale or merger of BRE. Wells Fargo Securities is acting as financial advisor and Latham & Watkins LLP is serving as legal advisor to BRE in connection with the review of strategic alternatives.
In connection with a solicitation of indications of interest by BRE, the Company has received a non-binding proposal from Essex Property Trust, Inc. (NYSE: ESS) (“Essex”) to acquire BRE in a negotiated merger in which each outstanding share of BRE common stock would be exchanged for 0.2971 shares of Essex common stock and $12.33 in cash. The companies are currently engaged in discussions regarding this proposal and have agreed to an exclusivity period.
The Company notes that no decision has been made by the Board regarding any particular alternative available to the Company (including any transaction with Essex) and that there can be no assurances that any transaction will be entered into or consummated. BRE does not intend to discuss or disclose developments with respect to this process unless and until the Board has approved a definitive course of action.
To keep up on all the Mergers & Acquisitions data in real-time, go to our M&A Insider page.
Hemispherx Biopharma, Inc. (NYSE: HEB) 37% HIGHER; announced that its Phase 1/2 clinical trial at the University of Alabama Vaccine Research Clinic is now being expanded based on an analysis of safety results to date conducted by both the Food and Drug Administration ("FDA") and a Data Monitoring Committee, the latter group comprised of a team of independent clinical, basic research, and statistical professionals.
Sysco Corp. (NYSE: SYY) 26.4% HIGHER; Sysco and US Foods announced an agreement to merge, creating a world-class foodservice company. The total enterprise value of the transaction is approximately $8.2 billion and the combination has been approved by the Board of Directors of each company.
Given Imaging Ltd (Nasdaq: GIVN) 25.4% HIGHER; Covidien plc (NYSE: COV) and Given Imaging Ltd (Nasdaq: GIVN) announced a definitive agreement under which Covidien will acquire all of the outstanding shares of Given Imaging for $30.00 per share in cash, for a total of approximately $860 million, net of cash and investments acquired. This transaction provides Covidien additional scale and scope to serve the multibillion dollar global gastrointestinal (GI) market and supports the Companys strategy to comprehensively address key global specialties and procedures.
UQM Technologies, Inc. (NYSE: UQM) 25.1% HIGHER; received approval from the U.S. Department of Energy ("DOE") for the continuation of the grant (the "Grant") under the American Recovery and Reinvestment Act. The Grant was originally awarded in 2010. As requested by the DOE in July 2013, the Company submitted a revised plan that analyzed the current status of the project to date, the Company's spending level run-rates since the commencement of the Grant, and projected spending required for the remainder of the program to meet all of the objectives of the Grant. Based on the Company's request, the DOE approved this resubmitted plan that included a budget with a revised total Grant amount of $64,782,343 (compared to $90,291,068 originally awarded) and reimbursable funding to the Company for qualifying project costs incurred up to a total of $32,391,171 (compared to $45,145,534 originally awarded). The period of the Grant is through January 12, 2015. Management expects that the Company's quarterly grant reimbursements through the duration of the program will be similar to prior quarters. While the total amount reimbursable under the Grant as continued is less than the amount of the original plan in 2010, based on progress in the program and costs to date, the Company believes it can accomplish all of the objectives sought in its original 2010 plan with the reimbursable amount continuing under the Grant pursuant to the revised plan.
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) 15.5% HIGHER; announced updated data from a Phase 1 study of IPI-145, its oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, in patients with chronic lymphocytic leukemia (CLL), a potentially fatal hematologic malignancy (blood cancer). Data from the study showed that IPI-145 was highly active in patients with relapsed/refractory CLL, with a nodal response rate of 89 percent and an overall response rate of 48 percent as defined by the International Workshop on Chronic Lymphocytic Leukemia (IWCLL) criteria1, including one complete response and 12 partial responses, among patients receiving IPI-145 at doses 25 mg twice daily (BID). Onset of activity was rapid, with the majority of responses occurring in less than two months. These data, along with safety data showing that IPI-145 was generally well tolerated, support DUO, Infinitys Phase 3 registration study of IPI-145 in patients with relapsed/refractory CLL, which is now enrolling patients.
Acura Pharmaceuticals, Inc. (Nasdaq: ACUR) 10% HIGHER; announced that it met on December 5th with the U.S. Food and Drug Administration (FDA) to review the results of Acuras Study AP-ADF-301 (Study 301), a phase II clinical study in 40 recreational drug abusers assessing the abuse liability of snorting a crushed hydrocodone bitartrate with acetaminophen tablet formulated with Acuras abuse deterrent AVERSION technology (AVERSION H&A). The primary purpose of the meeting was to discuss if the FDA will consider whether the results of Study 301 are acceptable for submission in a New Drug Application (NDA). The meeting was designated a pre-NDA meeting.
NII Holdings (NASDAQ: NIHD) 9.9% LOWER; to Cut HQ Stafff by 25%; Modifies Deactivation Policy
Dec 9, 2013 07:05 AM
Ceragon Networks (NASDAQ: CRNT) 9.2% HIGHER; Needham & Company initiates coverage with a Strong Buy rating and $8 price target, suggesting 217% upside from Friday's close.
Plug Power Inc. (Nasdaq: PLUG) 7.7% LOWER; pulls back after recent strong gains
ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) 5.7% HIGHER; announced positive interim results from its ongoing Phase 1/2 study of Ad-RTS-IL-12, a novel DNA-based therapeutic candidate that is being evaluated with the oral activator, veledimex, in patients with advanced melanoma. The results from this multicenter study were presented at Melanoma Bridge 2013 Conference at the session "Best Abstracts on News in Immunotherapy", an international conference co-sponsored by Istituto Nazionale Tumori Fondazione, Sidra Medical and Research Center, and the Society for ImmunoTherapy of Cancer that is being held in Naples, Italy.
InterOil (NYSE: IOC) 4.5% HIGHER; bounces after Friday's drubbing on the Total deal
Gilead Sciences, Inc. (Nasdaq: GILD) 3.7% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has approved Sovaldi (sofosbuvir) 400 mg tablets, a once-daily oral nucleotide analog polymerase inhibitor for the treatment of chronic hepatitisÂ C (CHC) infection as a component of a combination antiviral treatment regimen.
Alpha Natural Resources, Inc. (NYSE: ANR) 2.7% HIGHER; entered into an agreement to exchange its 50 percent interest in its Alpha Shale Resources Joint Venture with Rice Energy for $200 million of Rice common stock in Rice Energy's planned initial public offering and $100 million in cash, for total consideration of $300 million. Alpha and Rice Energy entered into the 50/50 joint venture in 2010 to develop a portion of Alpha's Marcellus natural gas holdings in Greene County, Pennsylvania.
EZCORP (NASDAQ: EZPW) 2.6% LOWER; Sterne Agee downgraded from Buy to Neutral with a price target of $12.00 (from $15.50).
BRE Properties, Inc. (NYSE: BRE) 2% LOWER; announced that its Board of Directors, working with its management team and the Company's advisors, has been in an ongoing process of exploring strategic alternatives to enhance shareholder value. The BRE Board has undertaken a comprehensive and thorough review of alternatives that include, among other things, a possible sale or merger of BRE. Wells Fargo Securities is acting as financial advisor and Latham & Watkins LLP is serving as legal advisor to BRE in connection with the review of strategic alternatives.
HollyFrontier (NYSE: HFC) 1.9% HIGHER; JPMorgan upgraded from Underweight to Overweight.
Chegg, Inc. (NYSE: CHGG) 1.5% HIGHER; new, positive analyst coverage
1. Friday morning, the U.S. Labor Deportment reported that nonfarm payroll employment rose by 203,000 during the month, well ahead of the 185,000 job gains economists expected on average. The unemployment rate declined from 7.3 percent to 7.0 percent. The number of unemployed persons fell to 10.9 million and the number of people who reported being on temporary layoff decreased by 377,000.
2. Wednesday night, Apple (Nasdaq: AAPL) and China Mobile (NYSE: CHL) were said to have signed a long-awaited iPhone deal. While no word was given from either part, speculation has China Mobile launching the iPhone on its network starting December 18th. China Mobile has 740 million wireless subscribers, though roughly 10 to 15 percent are 3G subs. For more color from Piper Jaffray analyst Gene Munster, click here.
3. U.S. GDP rose at an annual rate of 3.6 percent in the third quarter, according to the second estimate from the U.S. Department of Commerce. This was well ahead of the 3.1 percent increase expected by economists, up from the advanced estimates of 2.8 percent and up from the 2.5 percent growth in the second quarter. The government said the increase in private inventory investment was larger than previously estimated. For more color, click here.
4. On Wednesday, it was announced that General Growth Properties Inc. (NYSE: GGP) will replace Molex Inc. (Nasdaq: MOLX) in the S&P 500 after the close of trading on Monday, December 9. Privately held Koch Industries Inc. is acquiring Molex in a deal expected to be completed on that date. Investors are now question if, instead of when, Facebook (Nasdaq: FB) might be added to the index. For more explanation on the move, click here.
5. The Federal Reserve on Monday announced that it has not objected to re-submitted capital plans from The Goldman Sachs Group, Inc. (NYSE: GS) and JPMorgan Chase & Co. (NYSE: JPM). During the 2013 Comprehensive Capital Analysis and Review (CCAR), the Federal Reserve did not object to the capital plans from both institutions, but required them to submit new plans addressing weaknesses identified in their capital planning processes.
6. Virtual currency bitcoin has been the talk this week. The currency moved above $1,200 this week, but came back to earth after China's Central Bank said that it wasn't a currency. For those who haven't been following, we've set up an entity page here, which will allow you to track news on bitcoin as it happens.
7. Monday, the Dow Chemical Company (NYSE: DOW) detailed the scope of a separation of a significant portion of its chlorine value chain. These assets are being carved out for future transactions, and represent up to $5 billion of total annual revenue, inclusive of sales on the merchant market and sales to support Dow’s downstream, value-added products. The scope includes approximately 40 manufacturing facilities at 11 sites, and nearly 2,000 employees.
8. NCR Corporation (NYSE: NCR) announced Monday that it entered into a definitive agreement to purchase Digital Insight Corporation, a leader in online and mobile banking solutions, for a purchase price of $1.65 billion, and that it had completed the acquisition of Alaric Systems Limited, a provider of secure transaction switching and fraud prevention software, for a purchase price of approximately $84 million. Digital Insight is majority owned by Thoma Bravo, LLC.
9. J.C. Penney Co., Inc. (NYSE: JCP) had a tough week, worsening Thursday after the company disclosed in its 10-Q that on October 7, 2013, it received a letter of inquiry from the Securities and Exchange Commission (SEC) requesting information regarding it’s liquidity, cash position, and debt and equity financing, as well as it’s underwritten public offering of common stock announced on September 26, 2013. The Company is cooperating with the Securities and Exchange Commission in regards to its inquiry, including providing material requested by the Securities and Exchange Commission. Shares slipped as much as 9 percent Friday and fell over 19 percent for the week.
10. Barrick Gold Corporation (NYSE: ABX) announced that its Founder and Chairman, Peter Munk, will retire as Chairman of Barrick and will step down from the company's Board of Directors at the 2014 Annual Meeting of Shareholders (AGM). Munk founded Barrick in 1983, growing the company from a small junior producer with one mine into the global gold industry leader and a Canadian champion, with operations on five continents.
Before Markets Open:
Ingles Markets, Inc. (Nasdaq: IMKTA) - no Street consensus
Layne Christensen Co (Nasdaq: LAYN) - consensus loss $0.36
After Markets Close:
ABM Industries, Inc. (NYSE: ABM) - consensus EPS $0.45
Analogic Corp (Nasdaq: ALOG) - consensus EPS $0.87
Comtech Telecommunications (Nasdaq: CMTL) - consensus EPS $0.23
PVH Corp. (NYSE: PVH) - consensus EPS $2.24
Pep Boys (NYSE: PBY) - consensus EPS $0.14
Synergetics Usa, Inc. (Nasdaq: SURG) - consensus EPS $0.04
Vail Resorts, Inc. (NYSE: MTN) - consensus loss $1.91
Check out our Earnings Insider for news and updates on earnings as they happen!
More Special ReportsView Older Stories
Unusual 11 Mid-Day Movers 12/06: (MBLX) (VIFL) (BLDP) Higher; (RALY) (ULTA) (SEAC) Lower
Streetinsider.com's Hot Lunchtime Reads 12/06: (P) (BKS) (FRX) (CNP) (KNDI)
Notable Analyst Rating Changes 12/06: (PDS) (INTC) (HPQ) Upgraded; (GPS) (FDO) (SODA) Downgraded
Notable Mergers and Acquisitions of the Day 12/06: (IOC)/(TOT) (LKQ) (SHLD) (VIFL)
Pre-Open Stock Movers 12/6: (ENZN) (GERN) (PSUN) Higher; (IOC) (ULTA) (PWRD) Lower (more...)
After Hours Stock Movers 12/05: (ENZN) (PSUN) (FNSR) Higher; (ULTA) (SEAC) (BIG) Lower (more...)
Market Wrap: Mandela Passes Away; U.S. Shows Robust Growth in Q3; Diversifying Twitter
Notable 52-Week Highs and Lows of the Day 12/05: (PLUG) (CONN) (DG) High; (BBRY) (WTSL) (NEM) Low
Trading Radar for 12/06: Big Lots (BIG), American Eagle Outfitters (AEO), Ferrellgas Partners (FGP) Report
Unusual 11 Mid-Day Movers 12/05: (CALI) (PBYI) (MEI) Higher; (SOL) (WTSL) (NWY) lower
Streetinsider.com's Hot Lunchtime Reads 12/05: (RVBD) (JCP) (MSFT) (PVA)
Notable Analyst Rating Changes 12/05: (CELG) (KSS) (HK) Upgraded; (XOM) (SJM) (ALKS) Downgraded
Notable Mergers and Acquisitions of the Day 12/05: (CALI) (DDD) (NEM)
Pre-Open Stock Movers 12/5: (CALI) (CBMX) (MEI) Higher; (SOL) (WTSL) (FRAN) Lower (more...)
After Hours Stock Movers 12/4: (PBYI) (MFRM) (GGP) Higher; (LGP) (SNPS) (ARO) Lower (more...)
Market Wrap: Hayman Likes GM; Pandora Skirts Competition; Private Sector Jobs Bonanza
Trading Radar for 12/05: Kroger (KR), Dollar General (DG), Toro (TTC), UTI Worldwide (UTIW) Report
Notable 52-Week Highs and Lows of the Day 12/04: (PLUG) (GM) (LVS) High; (TC) (TRQ) Low
Unusual 11 Mid-Day Movers 12/04: (OCLS) (ABIO) (TNXP) Higher; (AMBI) (TRQ) (EXPR) Lower
Streetinsider.com's Hot Lunchtime Reads 12/04: (GM) (C) (TWTR) (MPEL)
Notable Analyst Rating Changes 12/04: (USB) (BBT) (JCI) Upgraded; (EBAY) (C) (EPB) Downgraded
Notable Mergers and Acquisitions of the Day 12/04: (EMR)/(SPW) (ESS)/(BRE) (PM) (MDCO)
Pre-Open Stock Movers 12/04: (OCLS) (PLUG) (OMED) Higher; (AMBI) (EXPR) (OVTI) Lower (more...)
After Hours Stock Movers 12/03: (CCXI) (GWRE) (JCP) Higher; (OVTI) (ACMP) (CLDX) Lower (more...)
Market Wrap: Detroit Bankruptcy Approved; Auto Sales Soar in November; Job Cuts at Potash
Notable 52-Week Highs and Lows of the Day 12/03: (UNIS) (MDLZ) (OMED) High; (FIO) (CIE) Low
Trading Radar for 12/04: Guess? (GES), Avago Tech (AVGO), Aeropostale (ARO), Express (EXPR) Report
Unusual 11 Mid-Day Movers 12/03: (OMED) (ETRM) (REX) Higher; (KKD) (ECTE) (YRCW) Lower
Streetinsider.com's Hot Lunchtime Reads 12/03: (QCOR) (MSFT) (AAPL) (ANF)
Notable Analyst Rating Changes 12/03: (ABBV) (AAPL) (FRX) Upgraded; (PFE) (DIS) (AT) Downgraded
Notable Mergers and Acquisitions of the Day 12/03: (NCR) (ASGN)/(CCRN) (OCZ) (NYLD)
Pre-Open Stock Movers 12/03: (OMED) (UNIS) (AAPL) Higher; (KKD) (CNAT) (ECTE) Lower (more...)
Streetinsider.com After-Hours Movers 12/02: (CNAT) (ASNA) (SCVL) Higher; (KKD) (GMAN) (TAXI) Lower
Market Wrap: Oct. Manufacturing Ramps; Black Friday Sales Slip; Dow Sells Chemical Assets
Notable 52-Week Highs and Lows of the Day 12/02: (GALE) (BOSC) (FRX) High; (CIE) (FTNT) Low
Trading Radar for 12/03: Omnivision (OVTI), Bob Evans (BOBE), LTX-Credence (LTXC), Universal Technical Institute (UTI) Report
Unusual 11 Mid-Day Movers 12/02: (BOSC) (VSCI) (DGLY) Higher; (ZOOM) (IR) (CIE) Lower
Notable Analyst Rating Changes 12/02: (RKUS) (AEO) (EBAY) Upgraded; (MMM) (GRPN) (XL) Downgraded
Notable Mergers and Acquisitions of the Day 12/02: (HES) (FRX) (CPN) (TDG)
Pre-Open Stock Movers 12/2: (MNST) (RKUS) (EBAY) Higher; (OREX) (ECOL) (GRPN) Lower (more...)
Top 10 News for 11/25-11/29: NASDAQ Crosses 4K, Bitcoin Crosses 1K and Black Friday Turns into Black Thursday
Pre-Open Stock Movers 11/29: (ZOOM) (FRO) (UPIP) Higher; (UEPS) (THOR) (IPCI) Lower (more...)
Market Wrap: AMR/US Airways Deal Gets Nod; More Optimistic Consumers; Berlusconi Out
After-Hours Stock Movers 11/27: (ZOOM) (DSS) (APP) Higher; (IPCI) (FTNT) Lower (more...)
Notable 52-Week Highs and Lows of the Day 11/27: (FWLT) (AMZN) (MU) High; (ACST) (NEM) (TLYS) Low
Unusual 11 Mid-Day Movers 11/27: (ATRM) (ELTK) (BIOS) Higher; (TLYS) (BLOX) (BRLI) Lower
Streetinsider.com's Hot Lunchtime Reads 11/27: (AVAV) (TSLA) (OREX) (VJET)
Notable Mergers and Acquisitions of the Day 11/27: (CVS) (FWLT) (CROX)
Pre-Open Stock Movers 11/27: (FRO) (GWPH) (HPQ) Higher; (TLYS) (BLOX) (ADI) Lower (more...)
After-Hours Stock Movers 11/26: (GWPH) (HPQ) (AVAV) Higher; (TLYS) (BLOX) (ADI) Lower (more...)